PeptiDream Inc. (TYO:4587)
1,025.50
+28.20 (2.83%)
Jun 26, 2026, 3:30 PM JST
PeptiDream Employees
PeptiDream had 645 employees as of December 31, 2025. The number of employees increased by 24 or 3.86% compared to the previous year.
Employees
645
Change (1Y)
24
Growth (1Y)
3.86%
Revenue / Employee
25.57M JPY
Profits / Employee
-4.79M JPY
Market Cap
131.77B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| GNI Group | 990 |
| Nxera Pharma | 354 |
| Oncolys BioPharma | 44 |
| SanBio Company | 33 |
| Healios K.K. | 75 |
| Cuorips | 56 |
| Japan Tissue Engineering | 200 |
| StemRIM | 45 |
PeptiDream News
- 17 days ago - PeptiDream Announces First Dosing of Claudin18.2 Targeting Radiopharmaceutical Candidate 64Cu-PD-29875 in Patients with Gastric Cancer - Business Wire
- 17 days ago - PeptiDream, PDRadiopharma and Curium Group Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan - Business Wire
- 17 days ago - Curium Group, PeptiDream and PDRadiopharma Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan - GlobeNewsWire
- 25 days ago - PeptiDream Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - PeptiDream Quarterly report: Q1 2026 - Filings
- 2 months ago - PeptiDream announces initiation of Phase 1 clinical trial of AK1940 - TheFly
- 2 months ago - PeptiDream Announces the Initiation of Phase 1 Clinical Trial by Its Collaboration Partner - Business Wire
- 3 months ago - PeptiDream downgraded to Neutral from Buy at Citi - TheFly